239
Participants
Start Date
April 22, 2015
Primary Completion Date
September 15, 2022
Study Completion Date
December 31, 2026
Erdafitinib
8 mg orally once daily for 28 days on a 28 day cycle.
Midazolam
Participants who enrolled in DDI substudy will receive pretreatment with single dose of midazolam on Day -2 and single dose of midazolam on Day 13.
Metformin
Participants who enrolled in DDI substudy will receive pretreatment with single dose of metformin on Day -1 and single dose of metformin on Day 14.
Sedona
Los Angeles
Orange
Sacramento
Stanford
Aurora
Washington D.C.
Chicago
Iowa City
Louisville
Minneapolis
Omaha
Las Vegas
New York
Charlotte
Medford
Tualatin
Hershey
Pittsburgh
Myrtle Beach
Nashville
Dallas
Denton
Houston
Hampton
Graz
Linz
Vienna
Aalst
Brussels
Charleroi
Ghent
Wilrijk
Angers
Bordeaux
Caen Cédex 05
Dijon
Lyon
Nice
Nîmes
Paris
Saint-Herblain
Suresnes
Villejuif
Berlin
Erlangen
Essen
Freiburg im Breisgau
Göttingen
Greifswald
Hamburg
Hanover
Heidelberg
München
Münster
Regensburg
Straubing
Weiden/Opf
Bangalore
Kolkata
Mira Road (East)
Nadiād
Beer Yaakov
Beersheba
Haifa
Kfar Saba
Petah Tikva
Tel Aviv
Chisinau
Bucharest
Cluj-Napoca
Craiova
Iași
Barnaul
Moscow
Omsk
Pyatigorsk
Saint Petersburg
Ufa
Daejeon
Goyang-si
Incheon
Seoul
Badalona
Barcelona
Madrid
Málaga
Pamplona
Sabadell
Santander
Santiago de Compostela
Seville
Valencia
Taichung
Tainan City
Taipei
Taoyuan District
Istanbul
Blackburn
Dundee
Essex
London
Metropolitan Borough of Wirral
Plymouth
Sutton
Janssen Research & Development, LLC
INDUSTRY